It is with great sadness that we must announce the closure of Jo's Cervical Cancer Trust, effective immediately Read More

Eluned Hughes, Head of Information and Engagement

Behind the headlines: Colposcopy delays in Greater Glasgow and Clyde

Posted on: Wednesday, 22nd February 2023 by

The Glasgow Times today published an article entitled "Glasgow campaigners slam year long wait for follow-up smear exam.” The article highlights the issue of long waiting times for colposcopy appointments in NHS Greater Glasgow and Clyde. This is something we have been hearing about more and more through our Helpline. It might be worrying to hear about delays and, even more so, being told you might have a long wait. Read on to find out what’s going on and what it means for you.

Categories: cell changes colposcopy

New treatment for advanced cervical cancer available in Scotland

Posted on: Monday, 13th February 2023 by

Behind the headlines: Scientists develop more accurate predictive test for cervical cancer

Posted on: Wednesday, 19th October 2022 by

You might have seen stories in newspapers today about a new kind of test for detecting cervical cell changes and helping prevent cervical cancer. A new study published this week has found that a new kind of test could be more accurate at detecting cervical cell changes, and better at predicting who might develop cell changes in the future.

Behind the headlines: One dose of the HPV vaccination

Posted on: Wednesday, 10th August 2022 by

Note: this blog was originally published on 10th August 2022 and updated on 20th June 2023 to include the latest announcements.

Categories: hpv vaccine

Gender identity in healthcare

Posted on: Thursday, 14th July 2022 by

At Jo’s, we work for women – that goes without saying – but we also recognise that not everyone with a cervix identifies as a woman. This week is Non-Binary Awareness Week, and this blog looks at the role of sample-taker and other GP staff in helping trans men and/or non-binary people with a cervix to feel welcomed and encouraged throughout their screening.